These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3705518)

  • 21. [Changes in the diabetogenic factor activity in the blood plasma of children with diabetes mellitus resulting from systematic heparin administration].
    Kudriashov BA; Zhukovskiĭ MA; Shcherbacheva LN; Ul'ianov AM; Bazaz'ian GG
    Pediatriia; 1985 Aug; (8):46-7. PubMed ID: 4069883
    [No Abstract]   [Full Text] [Related]  

  • 22. [The antiheparin thrombocyte factor 4 and its interaction with heparin].
    Liapina LA; Pastorova VE; Kudriashov BA
    Izv Akad Nauk SSSR Biol; 1990; (6):881-8. PubMed ID: 2074338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anticoagulant and nonenzymatic fibrinolytic activity of plasma in animals after intravenous injection of a heparin-antithrombin III complex].
    Kudriashov BA; Pastorova VE; Liapina LA
    Biull Eksp Biol Med; 1985 Jan; 99(1):62-4. PubMed ID: 3967074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Low-molecular heparin complex formation with the blood coagulation proteins--thrombin and fibrinogen].
    Kudriashov BA; Liapina LA; Pastorova VE; Kondashevskaia MV
    Izv Akad Nauk SSSR Biol; 1992; (5):802-6. PubMed ID: 1332992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of the pancreas in the appearance of the diabetogenic factor during the development of alloxan diabetes].
    Kudriashov BA; Tarasov IuA; Ul'ianov AM
    Patol Fiziol Eksp Ter; 1989; (3):75-9. PubMed ID: 2797907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [C-peptide, diabetogenic factor and the blood anticoagulating system in patients with the insulin-dependent type of diabetes mellitus before and after heparin therapy].
    Balabolkin MI; Kudriashov BA; Levitskaia ZI; Liapina LA; Ul'ianov AM
    Probl Endokrinol (Mosk); 1990; 36(1):25-8. PubMed ID: 2330356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of heparin on the activation of factor XI by fibrin-bound thrombin.
    von dem Borne PA; Meijers JC; Bouma BN
    Thromb Haemost; 1996 Sep; 76(3):347-53. PubMed ID: 8883269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of histones on nonenzymatic fibrinolysis in plasma].
    Liapina LA
    Vopr Med Khim; 1989; 35(1):37-41. PubMed ID: 2741397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The pancreas as a source of natural diabetogenic factor in alloxan diabetes].
    Kudriashov BA; Tarasov IuA; Ul'ianov AM
    Patol Fiziol Eksp Ter; 1991; (2):46-7. PubMed ID: 1881712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histidine-rich glycoprotein modulates the anticoagulant activity of heparin in human plasma.
    Lijnen HR; Van Hoef B; Collen D
    Thromb Haemost; 1984 Apr; 51(2):266-8. PubMed ID: 6740558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A primate model (Macaca mulatta) to study the pharmacokinetics of heparin and its fractions.
    Fareed J; Kumar A; Rock A; Walenga JM; Davis P
    Semin Thromb Hemost; 1985 Apr; 11(2):138-54. PubMed ID: 4035364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antidiabetogenic action of heparin during its oral administration].
    Ul'ianov AM; Tarasov IuA
    Patol Fiziol Eksp Ter; 1996; (1):21-3. PubMed ID: 8657446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Formation of streptokinase-heparin complexes and their properties].
    Nikandrov VN; Votiakov VI; Naumovich SA; Vorob'eva GV; Tsymanovich SG
    Vopr Med Khim; 1987; 33(2):54-8. PubMed ID: 3604141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Nature of the diabetogenic factor of blood plasma in clinical and experimental diabetes].
    Kudriashov BA; Liapina LA; Ul'ianov AM
    Probl Endokrinol (Mosk); 1985; 31(6):51-3. PubMed ID: 4088993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
    Rosenberg RD
    Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma thrombin clotting time and plasma fibrinogen in diabetes mellitus and atherosclerosis.
    Banerjee RN; Kumar V; Sahni AL
    Indian J Med Res; 1972 Oct; 60(10):1432-42. PubMed ID: 4661652
    [No Abstract]   [Full Text] [Related]  

  • 38. [The determination of heparin].
    Aiach M
    Ann Biol Clin (Paris); 1982; 40(6):645-50. PubMed ID: 7165134
    [No Abstract]   [Full Text] [Related]  

  • 39. [The content of a heparin-like anticoagulant in the flowers of the meadowsweet (Filipendula ulmaria)].
    Kudriashov BA; Liapina LA; Azieva LD
    Farmakol Toksikol; 1990; 53(4):39-41. PubMed ID: 2226759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutralization of the anticoagulant effects of glycosaminoglycans by serum amyloid P component: comparison with other plasma and platelet proteins.
    Williams EC; Huppert BJ; Asakura S
    J Lab Clin Med; 1992 Jul; 120(1):159-67. PubMed ID: 1377216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.